New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Urine of COVID-19 patients could predict who will develop severe disease

Urine of COVID-19 patients could predict who will develop severe disease

by American Physiological SocietyCredit: Unsplash/CC0 Public DomainUrine analysis of COVID-19 patients revealed elevated levels of specific biomarkers of the immune system compared to those who w
Immunology & Rheumatology April 10,2024
Urine of COVID-19 patients could predict who will develop severe disease

Urine of COVID-19 patients could predict who will develop severe disease

by American Physiological SocietyCredit: Unsplash/CC0 Public DomainUrine analysis of COVID-19 patients revealed elevated levels of specific biomarkers of the immune system compared to those who w
Immunology & Rheumatology April 10,2024
COVID-19: The older you are, the more antibodies you have

COVID-19: The older you are, the more antibodies you have

by University of MontrealA colorized scanning electron micrograph of the SARS-CoV-2 virus. Credit: NIAIDWith the emergence of SARS-CoV-2 variants worldwide, the pandemic's spread is accelerat
Immunology & Rheumatology April 10,2024
COVID-19: The older you are, the more antibodies you have

COVID-19: The older you are, the more antibodies you have

by University of MontrealA colorized scanning electron micrograph of the SARS-CoV-2 virus. Credit: NIAIDWith the emergence of SARS-CoV-2 variants worldwide, the pandemic's spread is accelerat
Immunology & Rheumatology April 10,2024
COVID-19: Not all antibodies are equal in fighting the virus

COVID-19: Not all antibodies are equal in fighting the virus

by University of MontrealA colorized scanning electron micrograph of the SARS-CoV-2 virus. Credit: NIAIDWhen a person is infected by SARS-CoV-2, the number of antibodies able to neutralize the vi
Immunology & Rheumatology April 10,2024
COVID-19: Not all antibodies are equal in fighting the virus

COVID-19: Not all antibodies are equal in fighting the virus

by University of MontrealA colorized scanning electron micrograph of the SARS-CoV-2 virus. Credit: NIAIDWhen a person is infected by SARS-CoV-2, the number of antibodies able to neutralize the vi
Immunology & Rheumatology April 10,2024
COVID-19 case severity: How genetic differences leave immune cells at a disadvantage

COVID-19 case severity: How genetic differences leave immune cells at a disadvantage

by La Jolla Institute for ImmunologyGenetic differences leave immune cells at a disadvantage. Credit: La Jolla Institute for ImmunologyNew research shows how genetic variations linked to severe c
Immunology & Rheumatology April 10,2024
COVID-19 case severity: How genetic differences leave immune cells at a disadvantage

COVID-19 case severity: How genetic differences leave immune cells at a disadvantage

by La Jolla Institute for ImmunologyGenetic differences leave immune cells at a disadvantage. Credit: La Jolla Institute for ImmunologyNew research shows how genetic variations linked to severe c
Immunology & Rheumatology April 10,2024
Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

by University of Alabama at BirminghamCredit: University of Alabama at BirminghamPreclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive resul
Immunology & Rheumatology April 10,2024
Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

by University of Alabama at BirminghamCredit: University of Alabama at BirminghamPreclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive resul
Immunology & Rheumatology April 10,2024
How CD4+ T cells respond to SARS-CoV-2 in COVID-19 recovered patients

How CD4+ T cells respond to SARS-CoV-2 in COVID-19 recovered patients

by Università della Svizzera italianaCredit: Università della Svizzera italianaAn international team of researchers from the Institute for Research in Biomedicine, affiliated to the Università della S
Public Health & Prevention April 10,2024
How CD4+ T cells respond to SARS-CoV-2 in COVID-19 recovered patients

How CD4+ T cells respond to SARS-CoV-2 in COVID-19 recovered patients

by Università della Svizzera italianaCredit: Università della Svizzera italianaAn international team of researchers from the Institute for Research in Biomedicine, affiliated to the Università della S
Public Health & Prevention April 10,2024
Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases

Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases

by Stefan Zorn, Medizinische Hochschule HannoverLevel of Problems Experienced by Patients. Patients were able to provide levels on a scale from 0 to 5 (0 = no problems, 5 = unable/extreme problems) fo
Public Health & Prevention April 10,2024
Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases

Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases

by Stefan Zorn, Medizinische Hochschule HannoverLevel of Problems Experienced by Patients. Patients were able to provide levels on a scale from 0 to 5 (0 = no problems, 5 = unable/extreme problems) fo
Public Health & Prevention April 10,2024
Simple test for COVID-19 could prioritize treatments for individuals most at risk

Simple test for COVID-19 could prioritize treatments for individuals most at risk

by Flinders UniversitySROC curve with 95% confidence region and prediction region for the SII towards prediction of severe disease or mortality. Credit:Frontiers in Immunology(2023).
Public Health & Prevention April 10,2024
Simple test for COVID-19 could prioritize treatments for individuals most at risk

Simple test for COVID-19 could prioritize treatments for individuals most at risk

by Flinders UniversitySROC curve with 95% confidence region and prediction region for the SII towards prediction of severe disease or mortality. Credit:Frontiers in Immunology(2023).
Public Health & Prevention April 10,2024
COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th
Public Health & Prevention April 10,2024
COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th
Public Health & Prevention April 10,2024
COVID-19 antibody testing needn't be perfect to guide public health and policy decisions

COVID-19 antibody testing needn't be perfect to guide public health and policy decisions

by University of Utah Health SciencesCredit: CC0 Public DomainWhile it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available t
Public Health & Prevention April 10,2024
COVID-19 antibody testing needn't be perfect to guide public health and policy decisions

COVID-19 antibody testing needn't be perfect to guide public health and policy decisions

by University of Utah Health SciencesCredit: CC0 Public DomainWhile it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available t
Public Health & Prevention April 10,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com